In a recent announcement, Cronos Group shared positive news regarding their performance in the fourth quarter. The Toronto-based cannabinoid company revealed a narrowed loss and higher revenue, attributed to successful sales in new international markets. Financial Insights Reduced Loss: Cronos Group reported a net loss of $44.8 million, or 12 cents per share, showcasing an … [Read more...] about Cronos Group Q4 Financial Reports
